BRPI0810096A8 - Anticorpo anti-epcam e seus usos - Google Patents
Anticorpo anti-epcam e seus usosInfo
- Publication number
- BRPI0810096A8 BRPI0810096A8 BRPI0810096A BRPI0810096A BRPI0810096A8 BR PI0810096 A8 BRPI0810096 A8 BR PI0810096A8 BR PI0810096 A BRPI0810096 A BR PI0810096A BR PI0810096 A BRPI0810096 A BR PI0810096A BR PI0810096 A8 BRPI0810096 A8 BR PI0810096A8
- Authority
- BR
- Brazil
- Prior art keywords
- epcam antibody
- diagnostic
- designated
- epcam
- antibody
- Prior art date
Links
- 241001529936 Murinae Species 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/39558—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against tumor tissues, cells, antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/77—Internalization into the cell
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Cell Biology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Oncology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
ANTICORPO ANTI-EPCAM E SEUS USOS. A presente invenção refere-se a um anticorpo anti_EpCAM, designado ST3232/10, de origem murina que exibe propriedades adequadas para ambas as aplicações de diagnóstico e terapêutica. Ele mostra alta afinidade pelo antígeno nativo e boa seletividade para o tumor.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP07105628 | 2007-04-04 | ||
PCT/EP2008/053913 WO2008122551A2 (en) | 2007-04-04 | 2008-04-02 | Anti-epcam antibody and uses thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
BRPI0810096A2 BRPI0810096A2 (pt) | 2014-10-21 |
BRPI0810096A8 true BRPI0810096A8 (pt) | 2017-12-26 |
Family
ID=38458122
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0810096A BRPI0810096A8 (pt) | 2007-04-04 | 2008-04-02 | Anticorpo anti-epcam e seus usos |
Country Status (21)
Country | Link |
---|---|
US (1) | US8318911B2 (pt) |
EP (1) | EP2142570B1 (pt) |
JP (1) | JP5631733B2 (pt) |
KR (1) | KR101683884B1 (pt) |
CN (1) | CN101970497B (pt) |
AT (1) | ATE512988T1 (pt) |
AU (1) | AU2008235566B2 (pt) |
BR (1) | BRPI0810096A8 (pt) |
CA (1) | CA2682296C (pt) |
CY (1) | CY1111819T1 (pt) |
DK (1) | DK2142570T3 (pt) |
EA (1) | EA023679B1 (pt) |
ES (1) | ES2367675T3 (pt) |
HR (1) | HRP20110620T1 (pt) |
IL (1) | IL201196A0 (pt) |
MX (1) | MX2009010444A (pt) |
PL (1) | PL2142570T3 (pt) |
PT (1) | PT2142570E (pt) |
RS (1) | RS52040B (pt) |
SI (1) | SI2142570T1 (pt) |
WO (1) | WO2008122551A2 (pt) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5686493B2 (ja) | 2003-01-24 | 2015-03-18 | ユニバーシティ・オブ・ユタUniversity Of Utah | テロメアの長さを決定することによって死亡の危険性を予測する方法 |
AU2009329987B2 (en) | 2008-12-22 | 2016-08-04 | University Of Utah Research Foundation | Monochrome multiplex quantitative PCR |
GB0909904D0 (en) * | 2009-06-09 | 2009-07-22 | Affitech As | Product |
AU2012228100B2 (en) | 2011-03-17 | 2016-09-08 | The University Of Birmingham | Re-directed immunotherapy |
EP2726870B1 (en) * | 2011-06-29 | 2018-10-03 | Academia Sinica | The capture, purification and release of biological substance using a surface coating |
WO2013131001A1 (en) * | 2012-03-02 | 2013-09-06 | Academia Sinica | ANTI-EPITHELIAL CELL ADHESION MOLECULE (EpCAM) ANTIBODIES AND METHODS OF USE THEREOF |
US9494500B2 (en) | 2012-10-29 | 2016-11-15 | Academia Sinica | Collection and concentration system for biologic substance of interest and use thereof |
CA2912216A1 (en) | 2013-05-22 | 2014-11-27 | Telomere Diagnostics, Inc. | Measures of short telomere abundance |
TW201623605A (zh) | 2014-04-01 | 2016-07-01 | 中央研究院 | 用於癌症診斷及預後之方法及系統 |
CN105381824B (zh) | 2014-08-26 | 2019-04-23 | 中央研究院 | 收集器架构布局设计 |
AU2015372584A1 (en) | 2014-12-30 | 2017-06-29 | Telomere Diagnostics, Inc. | Multiplex quantitative PCR |
US11098131B2 (en) | 2015-07-31 | 2021-08-24 | Sutro Biopharma, Inc. | Anti-EpCAM antibodies, compositions comprising anti-EpCAM antibodies and methods of making and using anti-EpCAM antibodies |
US10107726B2 (en) | 2016-03-16 | 2018-10-23 | Cellmax, Ltd. | Collection of suspended cells using a transferable membrane |
WO2017173091A1 (en) * | 2016-03-30 | 2017-10-05 | Musc Foundation For Research Development | Methods for treatment and diagnosis of cancer by targeting glycoprotein a repetitions predominant (garp) and for providing effective immunotherapy alone or in combination |
SG11201900634VA (en) | 2016-07-26 | 2019-02-27 | Tessa Therapeutics Pte Ltd | Chimeric antigen receptor |
WO2020018964A1 (en) | 2018-07-20 | 2020-01-23 | Fred Hutchinson Cancer Research Center | Compositions and methods for controlled expression of antigen-specific receptors |
US11702482B2 (en) | 2018-12-17 | 2023-07-18 | Revitope Limited | Twin immune cell engager |
WO2020216210A1 (zh) * | 2019-04-22 | 2020-10-29 | 江苏恒瑞医药股份有限公司 | 抗EpCAM抗体及其应用 |
AU2020292304B2 (en) * | 2019-06-11 | 2023-03-30 | Bioatla, Inc. | Conditionally active anti-EpCam antibodies, antibody fragments, their immunoconjugates and uses thereof |
CN110950959B (zh) * | 2020-02-25 | 2020-07-03 | 和铂医药(上海)有限责任公司 | 靶向EpCAM的抗体及其制备和应用 |
CN112094350B (zh) * | 2020-06-01 | 2024-01-05 | 普众发现医药科技(上海)有限公司 | 可应用于肿瘤细胞捕获的小鼠抗细胞表面糖蛋白cd326的单克隆抗体 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4675187A (en) | 1983-05-16 | 1987-06-23 | Bristol-Myers Company | BBM-1675, a new antibiotic complex |
US5525338A (en) | 1992-08-21 | 1996-06-11 | Immunomedics, Inc. | Detection and therapy of lesions with biotin/avidin conjugates |
IT1245748B (it) | 1990-12-21 | 1994-10-14 | Mini Ricerca Scient Tecnolog | Preparazione includente anticorpi monoclonali biotinilati, avidina e biotina, per la diagnosi di affezioni tumorali e suo impiego |
US5578287A (en) * | 1992-06-09 | 1996-11-26 | Neorx Corporation | Three-step pretargeting methods using improved biotin-active agent |
JP3427871B2 (ja) * | 1996-06-24 | 2003-07-22 | 戸田工業株式会社 | コバルト被着型針状磁性酸化鉄粒子粉末 |
ITRM20010079A1 (it) | 2001-02-16 | 2002-08-16 | Sigma Tau Ind Farmaceuti | Amminoderivati della biotina e loro coniugati con chelanti macrociclici. |
US20050180979A1 (en) * | 2004-02-13 | 2005-08-18 | Micromet Ag | Anti-EpCAM immunoglobulins |
US7435804B2 (en) | 2004-10-19 | 2008-10-14 | Phage Biotechnology, Inc. | Method for obtaining single chain antibodies to human interferon α2b |
-
2008
- 2008-04-02 US US12/594,559 patent/US8318911B2/en active Active
- 2008-04-02 ES ES08759374T patent/ES2367675T3/es active Active
- 2008-04-02 CN CN200880015767.4A patent/CN101970497B/zh not_active Expired - Fee Related
- 2008-04-02 AU AU2008235566A patent/AU2008235566B2/en not_active Ceased
- 2008-04-02 KR KR1020097023099A patent/KR101683884B1/ko active IP Right Grant
- 2008-04-02 WO PCT/EP2008/053913 patent/WO2008122551A2/en active Application Filing
- 2008-04-02 RS RS20110388A patent/RS52040B/en unknown
- 2008-04-02 BR BRPI0810096A patent/BRPI0810096A8/pt not_active Application Discontinuation
- 2008-04-02 EP EP08759374A patent/EP2142570B1/en active Active
- 2008-04-02 PL PL08759374T patent/PL2142570T3/pl unknown
- 2008-04-02 CA CA2682296A patent/CA2682296C/en not_active Expired - Fee Related
- 2008-04-02 PT PT08759374T patent/PT2142570E/pt unknown
- 2008-04-02 JP JP2010501503A patent/JP5631733B2/ja not_active Expired - Fee Related
- 2008-04-02 AT AT08759374T patent/ATE512988T1/de active
- 2008-04-02 MX MX2009010444A patent/MX2009010444A/es active IP Right Grant
- 2008-04-02 SI SI200830364T patent/SI2142570T1/sl unknown
- 2008-04-02 DK DK08759374.5T patent/DK2142570T3/da active
- 2008-04-02 EA EA200970923A patent/EA023679B1/ru not_active IP Right Cessation
-
2009
- 2009-09-24 IL IL201196A patent/IL201196A0/en active IP Right Grant
-
2011
- 2011-08-24 HR HR20110620T patent/HRP20110620T1/hr unknown
- 2011-09-06 CY CY20111100854T patent/CY1111819T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
HRP20110620T1 (hr) | 2011-09-30 |
AU2008235566B2 (en) | 2013-06-06 |
MX2009010444A (es) | 2009-10-20 |
WO2008122551A3 (en) | 2008-12-04 |
SI2142570T1 (sl) | 2012-01-31 |
DK2142570T3 (da) | 2011-10-03 |
WO2008122551A9 (en) | 2009-02-05 |
US8318911B2 (en) | 2012-11-27 |
CA2682296C (en) | 2017-02-28 |
ATE512988T1 (de) | 2011-07-15 |
CA2682296A1 (en) | 2008-10-16 |
RS52040B (en) | 2012-04-30 |
KR20100016237A (ko) | 2010-02-12 |
AU2008235566A1 (en) | 2008-10-16 |
CN101970497A (zh) | 2011-02-09 |
BRPI0810096A2 (pt) | 2014-10-21 |
ES2367675T3 (es) | 2011-11-07 |
CN101970497B (zh) | 2017-05-10 |
WO2008122551A2 (en) | 2008-10-16 |
US20100092491A1 (en) | 2010-04-15 |
PL2142570T3 (pl) | 2011-11-30 |
IL201196A0 (en) | 2010-05-17 |
CY1111819T1 (el) | 2015-10-07 |
EA200970923A1 (ru) | 2010-04-30 |
PT2142570E (pt) | 2011-09-13 |
EA023679B1 (ru) | 2016-06-30 |
KR101683884B1 (ko) | 2016-12-07 |
JP5631733B2 (ja) | 2014-11-26 |
EP2142570A2 (en) | 2010-01-13 |
JP2010523096A (ja) | 2010-07-15 |
EP2142570B1 (en) | 2011-06-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0810096A8 (pt) | Anticorpo anti-epcam e seus usos | |
CO2021002907A2 (es) | Constructos de anticuerpos para cldn18.2 y cd3 | |
BR112018071307A2 (pt) | anticorpos agonistas que ligam cd40 humana e usos dos mesmos | |
BR112018014615A2 (pt) | composições de anticorpo para ror1 e métodos relacionados | |
CY1118763T1 (el) | Αντισωμα αντι-ερηα2 | |
CR20150054A (es) | Anticuerpos anti-cxcr5 humanizados derivados de los mismos y su uso | |
BRPI0611800A2 (pt) | formulaÇço estÁvel de anticorpo | |
BR112016007112A2 (pt) | Anticorpos que se ligam a angiopoietina 2 (ang-2) humana, usos de um anticorpo que se liga a angiopoietina 2 (ang-2) humana e combinação | |
BRPI0906478B8 (pt) | anticorpo anti-nr10, seu uso e composição farmacêutica que o compreende | |
CR20130016A (es) | ANTICUERPOS PEPTIDICOS BETA AMILOIDE ANTI-N3pGlu Y USOS DE LOS MISMOS | |
BR112015017548A8 (pt) | construção de anticorpo multiespecífico isolado, sequência de ácido nucléico, vetor, célula hospedeira, processo para a produção da construção de anticorpo, composição farmaceutica, uso da construção de anticorpo e kit | |
ECSP14001249A (es) | Inmunoenlazadores dirigidos contra el tnf | |
BRPI0607676A2 (pt) | anticorpos contra isoformas de cspcna e usos destes | |
BR112013033258A2 (pt) | moléculas de ligação de anti-alfa sinucleína | |
BRPI0416141B8 (pt) | anticorpo anti-cd52 modificado, composição farmacêutica, vetores de expressão, e método para preparar uma imunoglobulina | |
GT201200271A (es) | Proteínas que se unen al tnf-a | |
CO6351750A2 (es) | Composiciones y métodos para anticuerpos que se dirigen a la proteina de complementos c5 | |
EA201201533A1 (ru) | Prlr-специфическое антитело и его применения | |
BR112013027829A2 (pt) | anticorpos anti-cd40 e método de uso | |
BR112012007523A2 (pt) | moléculas de anticorpo anti-gcc e composições e métodos relacionados | |
BR112014026740A2 (pt) | anticorpo, composição, métodos para tratar um mamífero e para fornecer um anticorpo com adcc realçada, e, uso de um anticorpo | |
BRPI0607323B8 (pt) | composições, usos de polipeptídeos e de anticorpos, bem como kits para a detecção de anticorpo que se liga especificamente a um polipeptídeo | |
ECSP088636A (es) | Antígenos de ácido des-n-acetil-siálico, anticuerpos para los mismos, y métodos de uso en la terapia de cáncer | |
BR112021025720A2 (pt) | Conjugados anticorpo-fármaco de fator antitecido e métodos relacionados | |
BR112016014413A2 (pt) | glicosiltransferase que glicosila o ácido flavoquermésico e/ou ácido quermésico |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B25A | Requested transfer of rights approved |
Owner name: ALFASIGMA S.P.A. (IT) |
|
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL |
|
B350 | Update of information on the portal [chapter 15.35 patent gazette] |